- Home
- PRQR vs CURV Comparison
PRQR vs CURV Comparison
Compare PRQR & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | CURV |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.5M | 226.9M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRQR | CURV |
|---|---|---|
| Price | $1.84 | $2.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $7.25 | $1.59 |
| AVG Volume (30 Days) | ★ 887.4K | 418.8K |
| Earning Date | 05-07-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $1,000,092,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.92 | $1.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.33 | $0.94 |
| 52 Week High | $3.10 | $2.86 |
Technical Indicators
Market Signals| Indicator | PRQR | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 47.38 |
| Support Level | $1.37 | $1.02 |
| Resistance Level | $1.99 | $2.85 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 7.92 | 22.50 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.